nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—SHBG—type 2 diabetes mellitus	0.226	0.608	CbGaD
Norethindrone—CYP3A4—type 2 diabetes mellitus	0.078	0.209	CbGaD
Norethindrone—ALB—type 2 diabetes mellitus	0.068	0.183	CbGaD
Norethindrone—ALB—Gliclazide—type 2 diabetes mellitus	0.0284	0.0641	CbGbCtD
Norethindrone—ALB—Repaglinide—type 2 diabetes mellitus	0.0267	0.0602	CbGbCtD
Norethindrone—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0223	0.0503	CbGbCtD
Norethindrone—ALB—Valsartan—type 2 diabetes mellitus	0.0197	0.0444	CbGbCtD
Norethindrone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0196	0.0442	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0196	0.0442	CbGbCtD
Norethindrone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0196	0.0442	CbGbCtD
Norethindrone—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0184	0.0415	CbGbCtD
Norethindrone—ALB—Nateglinide—type 2 diabetes mellitus	0.0183	0.0413	CbGbCtD
Norethindrone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0175	0.0394	CbGbCtD
Norethindrone—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0156	0.0353	CbGbCtD
Norethindrone—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0156	0.0353	CbGbCtD
Norethindrone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0147	0.0332	CbGbCtD
Norethindrone—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0144	0.0326	CbGbCtD
Norethindrone—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0139	0.0315	CbGbCtD
Norethindrone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0126	0.0285	CbGbCtD
Norethindrone—ALB—Glyburide—type 2 diabetes mellitus	0.0124	0.0279	CbGbCtD
Norethindrone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0117	0.0265	CbGbCtD
Norethindrone—ALB—Losartan—type 2 diabetes mellitus	0.0113	0.0255	CbGbCtD
Norethindrone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0105	0.0236	CbGbCtD
Norethindrone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00957	0.0216	CbGbCtD
Norethindrone—CYP3A5—Losartan—type 2 diabetes mellitus	0.00908	0.0205	CbGbCtD
Norethindrone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00867	0.0196	CbGbCtD
Norethindrone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00836	0.0189	CbGbCtD
Norethindrone—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00801	0.0181	CbGbCtD
Norethindrone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00756	0.0171	CbGbCtD
Norethindrone—CYP2C19—Losartan—type 2 diabetes mellitus	0.00732	0.0165	CbGbCtD
Norethindrone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00646	0.0146	CbGbCtD
Norethindrone—ABCB1—Losartan—type 2 diabetes mellitus	0.00591	0.0133	CbGbCtD
Norethindrone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00573	0.0129	CbGbCtD
Norethindrone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00549	0.0124	CbGbCtD
Norethindrone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00549	0.0124	CbGbCtD
Norethindrone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0052	0.0117	CbGbCtD
Norethindrone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00387	0.00874	CbGbCtD
Norethindrone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00354	0.00799	CbGbCtD
Norethindrone—SHBG—hindlimb—type 2 diabetes mellitus	0.00155	0.2	CbGeAlD
Norethindrone—PGR—artery—type 2 diabetes mellitus	0.000854	0.11	CbGeAlD
Norethindrone—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000464	0.06	CbGeAlD
Norethindrone—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000397	0.0513	CbGeAlD
Norethindrone—Levonorgestrel—SRD5A1—type 2 diabetes mellitus	0.00037	0.0811	CrCbGaD
Norethindrone—SHBG—cardiovascular system—type 2 diabetes mellitus	0.000329	0.0426	CbGeAlD
Norethindrone—Stanozolol—AR—type 2 diabetes mellitus	0.000309	0.0678	CrCbGaD
Norethindrone—CYP3A7—liver—type 2 diabetes mellitus	0.000303	0.0392	CbGeAlD
Norethindrone—PGR—cardiovascular system—type 2 diabetes mellitus	0.000297	0.0384	CbGeAlD
Norethindrone—SHBG—adipose tissue—type 2 diabetes mellitus	0.000291	0.0375	CbGeAlD
Norethindrone—Oxandrolone—AR—type 2 diabetes mellitus	0.000278	0.0611	CrCbGaD
Norethindrone—PGR—adipose tissue—type 2 diabetes mellitus	0.000262	0.0338	CbGeAlD
Norethindrone—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000258	0.0333	CbGeAlD
Norethindrone—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000239	0.0308	CbGeAlD
Norethindrone—Desogestrel—SHBG—type 2 diabetes mellitus	0.000219	0.048	CrCbGaD
Norethindrone—Nandrolone phenpropionate—AR—type 2 diabetes mellitus	0.000218	0.0478	CrCbGaD
Norethindrone—SHBG—liver—type 2 diabetes mellitus	0.000204	0.0263	CbGeAlD
Norethindrone—Danazol—CCL2—type 2 diabetes mellitus	0.0002	0.044	CrCbGaD
Norethindrone—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000192	0.0248	CbGeAlD
Norethindrone—Etonogestrel—SHBG—type 2 diabetes mellitus	0.000177	0.0388	CrCbGaD
Norethindrone—CYP3A5—kidney—type 2 diabetes mellitus	0.000169	0.0218	CbGeAlD
Norethindrone—ALB—liver—type 2 diabetes mellitus	0.000168	0.0217	CbGeAlD
Norethindrone—CYP3A5—pancreas—type 2 diabetes mellitus	0.000168	0.0217	CbGeAlD
Norethindrone—Nandrolone decanoate—AR—type 2 diabetes mellitus	0.000165	0.0362	CrCbGaD
Norethindrone—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000164	0.0213	CbGeAlD
Norethindrone—Norgestimate—ABCC2—type 2 diabetes mellitus	0.00016	0.035	CrCbGaD
Norethindrone—Alopecia—Valsartan—type 2 diabetes mellitus	0.000158	0.00127	CcSEcCtD
Norethindrone—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000156	0.00126	CcSEcCtD
Norethindrone—Alopecia—Orlistat—type 2 diabetes mellitus	0.000156	0.00126	CcSEcCtD
Norethindrone—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000155	0.00125	CcSEcCtD
Norethindrone—Oedema—Glyburide—type 2 diabetes mellitus	0.000154	0.00124	CcSEcCtD
Norethindrone—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000153	0.00124	CcSEcCtD
Norethindrone—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000153	0.00124	CcSEcCtD
Norethindrone—Flatulence—Valsartan—type 2 diabetes mellitus	0.000153	0.00124	CcSEcCtD
Norethindrone—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000152	0.00123	CcSEcCtD
Norethindrone—Rash—Repaglinide—type 2 diabetes mellitus	0.000152	0.00123	CcSEcCtD
Norethindrone—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000152	0.0197	CbGeAlD
Norethindrone—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000152	0.00123	CcSEcCtD
Norethindrone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000152	0.00123	CcSEcCtD
Norethindrone—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000152	0.00123	CcSEcCtD
Norethindrone—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000152	0.00123	CcSEcCtD
Norethindrone—Flatulence—Orlistat—type 2 diabetes mellitus	0.000151	0.00122	CcSEcCtD
Norethindrone—Headache—Repaglinide—type 2 diabetes mellitus	0.000151	0.00122	CcSEcCtD
Norethindrone—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000151	0.00122	CcSEcCtD
Norethindrone—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000151	0.00122	CcSEcCtD
Norethindrone—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000149	0.00121	CcSEcCtD
Norethindrone—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000148	0.00119	CcSEcCtD
Norethindrone—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000148	0.00119	CcSEcCtD
Norethindrone—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000148	0.00119	CcSEcCtD
Norethindrone—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000147	0.00119	CcSEcCtD
Norethindrone—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000147	0.00119	CcSEcCtD
Norethindrone—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000147	0.00118	CcSEcCtD
Norethindrone—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000147	0.00118	CcSEcCtD
Norethindrone—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000147	0.00118	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000145	0.00117	CcSEcCtD
Norethindrone—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000145	0.00117	CcSEcCtD
Norethindrone—Hepatitis—Losartan—type 2 diabetes mellitus	0.000144	0.00116	CcSEcCtD
Norethindrone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000144	0.00116	CcSEcCtD
Norethindrone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000144	0.00116	CcSEcCtD
Norethindrone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000143	0.00116	CcSEcCtD
Norethindrone—Asthenia—Glipizide—type 2 diabetes mellitus	0.000143	0.00116	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000143	0.00115	CcSEcCtD
Norethindrone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000143	0.00115	CcSEcCtD
Norethindrone—Pruritus—Glipizide—type 2 diabetes mellitus	0.000141	0.00114	CcSEcCtD
Norethindrone—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000141	0.00114	CcSEcCtD
Norethindrone—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000141	0.00114	CcSEcCtD
Norethindrone—Weight increased—Ramipril—type 2 diabetes mellitus	0.000141	0.00114	CcSEcCtD
Norethindrone—Flatulence—Metformin—type 2 diabetes mellitus	0.000139	0.00112	CcSEcCtD
Norethindrone—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000139	0.00112	CcSEcCtD
Norethindrone—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000137	0.00111	CcSEcCtD
Norethindrone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000137	0.00111	CcSEcCtD
Norethindrone—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000137	0.00111	CcSEcCtD
Norethindrone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000137	0.0011	CcSEcCtD
Norethindrone—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000136	0.0011	CcSEcCtD
Norethindrone—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000136	0.0011	CcSEcCtD
Norethindrone—Renal failure—Ramipril—type 2 diabetes mellitus	0.000136	0.00109	CcSEcCtD
Norethindrone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000136	0.00109	CcSEcCtD
Norethindrone—CYP2C19—liver—type 2 diabetes mellitus	0.000135	0.0175	CbGeAlD
Norethindrone—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000135	0.00109	CcSEcCtD
Norethindrone—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000135	0.00109	CcSEcCtD
Norethindrone—Drospirenone—AR—type 2 diabetes mellitus	0.000135	0.0295	CrCbGaD
Norethindrone—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000134	0.00108	CcSEcCtD
Norethindrone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000134	0.00108	CcSEcCtD
Norethindrone—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000134	0.00108	CcSEcCtD
Norethindrone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000133	0.00108	CcSEcCtD
Norethindrone—Convulsion—Orlistat—type 2 diabetes mellitus	0.000133	0.00107	CcSEcCtD
Norethindrone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000133	0.00107	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000133	0.00107	CcSEcCtD
Norethindrone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000132	0.00107	CcSEcCtD
Norethindrone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000132	0.00106	CcSEcCtD
Norethindrone—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000132	0.00106	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000131	0.00106	CcSEcCtD
Norethindrone—Tension—Irbesartan—type 2 diabetes mellitus	0.000131	0.00106	CcSEcCtD
Norethindrone—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.00013	0.00105	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00013	0.00105	CcSEcCtD
Norethindrone—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00013	0.00105	CcSEcCtD
Norethindrone—Alopecia—Losartan—type 2 diabetes mellitus	0.000128	0.00103	CcSEcCtD
Norethindrone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000127	0.00102	CcSEcCtD
Norethindrone—Oedema—Valsartan—type 2 diabetes mellitus	0.000127	0.00102	CcSEcCtD
Norethindrone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000127	0.00102	CcSEcCtD
Norethindrone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000127	0.0164	CbGeAlD
Norethindrone—CYP3A4—kidney—type 2 diabetes mellitus	0.000127	0.0164	CbGeAlD
Norethindrone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000127	0.00102	CcSEcCtD
Norethindrone—Rash—Glipizide—type 2 diabetes mellitus	0.000126	0.00102	CcSEcCtD
Norethindrone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000126	0.00102	CcSEcCtD
Norethindrone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000126	0.00101	CcSEcCtD
Norethindrone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000125	0.00101	CcSEcCtD
Norethindrone—Oedema—Orlistat—type 2 diabetes mellitus	0.000125	0.00101	CcSEcCtD
Norethindrone—Levonorgestrel—SHBG—type 2 diabetes mellitus	0.000125	0.0275	CrCbGaD
Norethindrone—Headache—Glipizide—type 2 diabetes mellitus	0.000125	0.00101	CcSEcCtD
Norethindrone—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000125	0.00101	CcSEcCtD
Norethindrone—Flatulence—Losartan—type 2 diabetes mellitus	0.000124	0.000999	CcSEcCtD
Norethindrone—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000124	0.000999	CcSEcCtD
Norethindrone—Tension—Losartan—type 2 diabetes mellitus	0.000123	0.000995	CcSEcCtD
Norethindrone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000123	0.000994	CcSEcCtD
Norethindrone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000123	0.000994	CcSEcCtD
Norethindrone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000991	CcSEcCtD
Norethindrone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000123	0.00099	CcSEcCtD
Norethindrone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000122	0.000985	CcSEcCtD
Norethindrone—Nervousness—Losartan—type 2 diabetes mellitus	0.000122	0.000985	CcSEcCtD
Norethindrone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000122	0.000982	CcSEcCtD
Norethindrone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000122	0.000981	CcSEcCtD
Norethindrone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000122	0.00098	CcSEcCtD
Norethindrone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000121	0.00098	CcSEcCtD
Norethindrone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000973	CcSEcCtD
Norethindrone—Headache—Pioglitazone—type 2 diabetes mellitus	0.00012	0.000967	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00012	0.000965	CcSEcCtD
Norethindrone—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000119	0.0262	CrCbGaD
Norethindrone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000119	0.000961	CcSEcCtD
Norethindrone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000119	0.00096	CcSEcCtD
Norethindrone—Nausea—Glipizide—type 2 diabetes mellitus	0.000119	0.000957	CcSEcCtD
Norethindrone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000118	0.000956	CcSEcCtD
Norethindrone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000118	0.000953	CcSEcCtD
Norethindrone—Rash—Glimepiride—type 2 diabetes mellitus	0.000118	0.000948	CcSEcCtD
Norethindrone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000117	0.000947	CcSEcCtD
Norethindrone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000117	0.000945	CcSEcCtD
Norethindrone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000117	0.000944	CcSEcCtD
Norethindrone—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000117	0.000944	CcSEcCtD
Norethindrone—Headache—Glimepiride—type 2 diabetes mellitus	0.000117	0.000942	CcSEcCtD
Norethindrone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000939	CcSEcCtD
Norethindrone—Oedema—Metformin—type 2 diabetes mellitus	0.000115	0.000932	CcSEcCtD
Norethindrone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000115	0.000925	CcSEcCtD
Norethindrone—Danazol—SHBG—type 2 diabetes mellitus	0.000114	0.025	CrCbGaD
Norethindrone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000113	0.000914	CcSEcCtD
Norethindrone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000113	0.000914	CcSEcCtD
Norethindrone—Testosterone Propionate—AR—type 2 diabetes mellitus	0.000113	0.0248	CrCbGaD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000113	0.000911	CcSEcCtD
Norethindrone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000113	0.000911	CcSEcCtD
Norethindrone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000113	0.000909	CcSEcCtD
Norethindrone—Skin disorder—Metformin—type 2 diabetes mellitus	0.000112	0.000905	CcSEcCtD
Norethindrone—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000112	0.000902	CcSEcCtD
Norethindrone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000112	0.000901	CcSEcCtD
Norethindrone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000897	CcSEcCtD
Norethindrone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000111	0.000893	CcSEcCtD
Norethindrone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00011	0.00089	CcSEcCtD
Norethindrone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00011	0.00089	CcSEcCtD
Norethindrone—Asthenia—Glyburide—type 2 diabetes mellitus	0.00011	0.00089	CcSEcCtD
Norethindrone—Levonorgestrel—AR—type 2 diabetes mellitus	0.00011	0.0241	CrCbGaD
Norethindrone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00011	0.000885	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000109	0.000883	CcSEcCtD
Norethindrone—Alopecia—Ramipril—type 2 diabetes mellitus	0.000109	0.000882	CcSEcCtD
Norethindrone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000109	0.000882	CcSEcCtD
Norethindrone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000109	0.00088	CcSEcCtD
Norethindrone—Oedema—Irbesartan—type 2 diabetes mellitus	0.000109	0.000879	CcSEcCtD
Norethindrone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000109	0.000879	CcSEcCtD
Norethindrone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000109	0.000877	CcSEcCtD
Norethindrone—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.000875	CcSEcCtD
Norethindrone—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000108	0.0238	CrCbGaD
Norethindrone—ABCB1—retina—type 2 diabetes mellitus	0.000108	0.014	CbGeAlD
Norethindrone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000108	0.000873	CcSEcCtD
Norethindrone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000108	0.000872	CcSEcCtD
Norethindrone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000107	0.000862	CcSEcCtD
Norethindrone—CYP3A5—liver—type 2 diabetes mellitus	0.000107	0.0138	CbGeAlD
Norethindrone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000855	CcSEcCtD
Norethindrone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000855	CcSEcCtD
Norethindrone—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000106	0.000854	CcSEcCtD
Norethindrone—Tension—Ramipril—type 2 diabetes mellitus	0.000106	0.000853	CcSEcCtD
Norethindrone—Ethinyl Estradiol—SHBG—type 2 diabetes mellitus	0.000106	0.0231	CrCbGaD
Norethindrone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000105	0.00085	CcSEcCtD
Norethindrone—Nervousness—Ramipril—type 2 diabetes mellitus	0.000105	0.000844	CcSEcCtD
Norethindrone—Fluoxymesterone—AR—type 2 diabetes mellitus	0.000105	0.023	CrCbGaD
Norethindrone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000104	0.000837	CcSEcCtD
Norethindrone—Somnolence—Metformin—type 2 diabetes mellitus	0.000103	0.000828	CcSEcCtD
Norethindrone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000103	0.000827	CcSEcCtD
Norethindrone—Oedema—Losartan—type 2 diabetes mellitus	0.000103	0.000827	CcSEcCtD
Norethindrone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000102	0.000827	CcSEcCtD
Norethindrone—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000102	0.0132	CbGeAlD
Norethindrone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000102	0.00082	CcSEcCtD
Norethindrone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000102	0.00082	CcSEcCtD
Norethindrone—Urticaria—Valsartan—type 2 diabetes mellitus	0.000101	0.000813	CcSEcCtD
Norethindrone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.0001	0.000809	CcSEcCtD
Norethindrone—Danazol—AR—type 2 diabetes mellitus	0.0001	0.0219	CrCbGaD
Norethindrone—Nausea—Bromocriptine—type 2 diabetes mellitus	9.99e-05	0.000806	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.97e-05	0.000804	CcSEcCtD
Norethindrone—Fatigue—Metformin—type 2 diabetes mellitus	9.96e-05	0.000803	CcSEcCtD
Norethindrone—Urticaria—Orlistat—type 2 diabetes mellitus	9.95e-05	0.000803	CcSEcCtD
Norethindrone—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.9e-05	0.000799	CcSEcCtD
Norethindrone—Asthenia—Gliclazide—type 2 diabetes mellitus	9.9e-05	0.000799	CcSEcCtD
Norethindrone—Vomiting—Glyburide—type 2 diabetes mellitus	9.77e-05	0.000788	CcSEcCtD
Norethindrone—Pruritus—Gliclazide—type 2 diabetes mellitus	9.76e-05	0.000788	CcSEcCtD
Norethindrone—Rash—Glyburide—type 2 diabetes mellitus	9.69e-05	0.000782	CcSEcCtD
Norethindrone—Somnolence—Irbesartan—type 2 diabetes mellitus	9.69e-05	0.000782	CcSEcCtD
Norethindrone—Dermatitis—Glyburide—type 2 diabetes mellitus	9.68e-05	0.000781	CcSEcCtD
Norethindrone—Methyltestosterone—SHBG—type 2 diabetes mellitus	9.64e-05	0.0211	CrCbGaD
Norethindrone—Headache—Glyburide—type 2 diabetes mellitus	9.63e-05	0.000777	CcSEcCtD
Norethindrone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.000774	CcSEcCtD
Norethindrone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.44e-05	0.000762	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.41e-05	0.000759	CcSEcCtD
Norethindrone—Fatigue—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000758	CcSEcCtD
Norethindrone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.34e-05	0.000754	CcSEcCtD
Norethindrone—Convulsion—Ramipril—type 2 diabetes mellitus	9.34e-05	0.000753	CcSEcCtD
Norethindrone—Insomnia—Losartan—type 2 diabetes mellitus	9.28e-05	0.000748	CcSEcCtD
Norethindrone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.23e-05	0.000745	CcSEcCtD
Norethindrone—Urticaria—Metformin—type 2 diabetes mellitus	9.17e-05	0.00074	CcSEcCtD
Norethindrone—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.17e-05	0.0118	CbGeAlD
Norethindrone—Nausea—Glyburide—type 2 diabetes mellitus	9.13e-05	0.000737	CcSEcCtD
Norethindrone—Abdominal pain—Metformin—type 2 diabetes mellitus	9.13e-05	0.000736	CcSEcCtD
Norethindrone—Dizziness—Gliclazide—type 2 diabetes mellitus	9.13e-05	0.000736	CcSEcCtD
Norethindrone—Somnolence—Losartan—type 2 diabetes mellitus	9.12e-05	0.000736	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000735	CcSEcCtD
Norethindrone—Asthenia—Valsartan—type 2 diabetes mellitus	9.1e-05	0.000734	CcSEcCtD
Norethindrone—Dyspepsia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000728	CcSEcCtD
Norethindrone—Asthenia—Orlistat—type 2 diabetes mellitus	8.99e-05	0.000725	CcSEcCtD
Norethindrone—Pruritus—Valsartan—type 2 diabetes mellitus	8.97e-05	0.000724	CcSEcCtD
Norethindrone—ABCB1—kidney—type 2 diabetes mellitus	8.97e-05	0.0116	CbGeAlD
Norethindrone—ABCB1—pancreas—type 2 diabetes mellitus	8.91e-05	0.0115	CbGeAlD
Norethindrone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.91e-05	0.000719	CcSEcCtD
Norethindrone—Pruritus—Orlistat—type 2 diabetes mellitus	8.86e-05	0.000715	CcSEcCtD
Norethindrone—Fatigue—Losartan—type 2 diabetes mellitus	8.84e-05	0.000713	CcSEcCtD
Norethindrone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000709	CcSEcCtD
Norethindrone—Oedema—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000709	CcSEcCtD
Norethindrone—Vomiting—Gliclazide—type 2 diabetes mellitus	8.77e-05	0.000708	CcSEcCtD
Norethindrone—ABCB1—cortex of kidney—type 2 diabetes mellitus	8.74e-05	0.0113	CbGeAlD
Norethindrone—Rash—Gliclazide—type 2 diabetes mellitus	8.7e-05	0.000702	CcSEcCtD
Norethindrone—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.69e-05	0.000701	CcSEcCtD
Norethindrone—Urticaria—Irbesartan—type 2 diabetes mellitus	8.66e-05	0.000698	CcSEcCtD
Norethindrone—Headache—Gliclazide—type 2 diabetes mellitus	8.65e-05	0.000698	CcSEcCtD
Norethindrone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.61e-05	0.000695	CcSEcCtD
Norethindrone—Skin disorder—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000689	CcSEcCtD
Norethindrone—Methyltestosterone—AR—type 2 diabetes mellitus	8.45e-05	0.0185	CrCbGaD
Norethindrone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.39e-05	0.000677	CcSEcCtD
Norethindrone—Dizziness—Valsartan—type 2 diabetes mellitus	8.38e-05	0.000677	CcSEcCtD
Norethindrone—Dizziness—Orlistat—type 2 diabetes mellitus	8.29e-05	0.000668	CcSEcCtD
Norethindrone—Asthenia—Metformin—type 2 diabetes mellitus	8.28e-05	0.000668	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ABCC2—type 2 diabetes mellitus	8.23e-05	0.0181	CrCbGaD
Norethindrone—Nausea—Gliclazide—type 2 diabetes mellitus	8.2e-05	0.000661	CcSEcCtD
Norethindrone—Pruritus—Metformin—type 2 diabetes mellitus	8.17e-05	0.000659	CcSEcCtD
Norethindrone—Urticaria—Losartan—type 2 diabetes mellitus	8.15e-05	0.000657	CcSEcCtD
Norethindrone—Abdominal pain—Losartan—type 2 diabetes mellitus	8.11e-05	0.000654	CcSEcCtD
Norethindrone—ABCB1—adipose tissue—type 2 diabetes mellitus	8.08e-05	0.0104	CbGeAlD
Norethindrone—Vomiting—Valsartan—type 2 diabetes mellitus	8.06e-05	0.00065	CcSEcCtD
Norethindrone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.03e-05	0.000648	CcSEcCtD
Norethindrone—CYP3A4—liver—type 2 diabetes mellitus	8.01e-05	0.0104	CbGeAlD
Norethindrone—Rash—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000645	CcSEcCtD
Norethindrone—Dermatitis—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000644	CcSEcCtD
Norethindrone—Vomiting—Orlistat—type 2 diabetes mellitus	7.97e-05	0.000643	CcSEcCtD
Norethindrone—Insomnia—Ramipril—type 2 diabetes mellitus	7.95e-05	0.000642	CcSEcCtD
Norethindrone—Headache—Valsartan—type 2 diabetes mellitus	7.94e-05	0.000641	CcSEcCtD
Norethindrone—Testosterone—CYP11A1—type 2 diabetes mellitus	7.93e-05	0.0174	CrCbGaD
Norethindrone—Rash—Orlistat—type 2 diabetes mellitus	7.9e-05	0.000637	CcSEcCtD
Norethindrone—Dermatitis—Orlistat—type 2 diabetes mellitus	7.89e-05	0.000637	CcSEcCtD
Norethindrone—Headache—Orlistat—type 2 diabetes mellitus	7.85e-05	0.000633	CcSEcCtD
Norethindrone—Allylestrenol—CYP3A4—type 2 diabetes mellitus	7.83e-05	0.0172	CrCbGaD
Norethindrone—Asthenia—Irbesartan—type 2 diabetes mellitus	7.82e-05	0.000631	CcSEcCtD
Norethindrone—Somnolence—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000631	CcSEcCtD
Norethindrone—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000625	CcSEcCtD
Norethindrone—Pruritus—Irbesartan—type 2 diabetes mellitus	7.71e-05	0.000622	CcSEcCtD
Norethindrone—Dizziness—Metformin—type 2 diabetes mellitus	7.64e-05	0.000616	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000613	CcSEcCtD
Norethindrone—Fatigue—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000612	CcSEcCtD
Norethindrone—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.56e-05	0.00061	CcSEcCtD
Norethindrone—Nausea—Valsartan—type 2 diabetes mellitus	7.53e-05	0.000608	CcSEcCtD
Norethindrone—Nausea—Orlistat—type 2 diabetes mellitus	7.44e-05	0.0006	CcSEcCtD
Norethindrone—Asthenia—Losartan—type 2 diabetes mellitus	7.36e-05	0.000594	CcSEcCtD
Norethindrone—Vomiting—Metformin—type 2 diabetes mellitus	7.34e-05	0.000592	CcSEcCtD
Norethindrone—Rash—Metformin—type 2 diabetes mellitus	7.28e-05	0.000587	CcSEcCtD
Norethindrone—Dermatitis—Metformin—type 2 diabetes mellitus	7.27e-05	0.000587	CcSEcCtD
Norethindrone—Hydrocortisone—SHBG—type 2 diabetes mellitus	7.26e-05	0.0159	CrCbGaD
Norethindrone—Pruritus—Losartan—type 2 diabetes mellitus	7.26e-05	0.000585	CcSEcCtD
Norethindrone—Headache—Metformin—type 2 diabetes mellitus	7.23e-05	0.000584	CcSEcCtD
Norethindrone—Dizziness—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000581	CcSEcCtD
Norethindrone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.19e-05	0.00058	CcSEcCtD
Norethindrone—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	7.1e-05	0.0156	CrCbGaD
Norethindrone—Urticaria—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000564	CcSEcCtD
Norethindrone—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000561	CcSEcCtD
Norethindrone—Vomiting—Irbesartan—type 2 diabetes mellitus	6.93e-05	0.000559	CcSEcCtD
Norethindrone—Rash—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000554	CcSEcCtD
Norethindrone—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000554	CcSEcCtD
Norethindrone—Nausea—Metformin—type 2 diabetes mellitus	6.86e-05	0.000553	CcSEcCtD
Norethindrone—Headache—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000551	CcSEcCtD
Norethindrone—Dizziness—Losartan—type 2 diabetes mellitus	6.78e-05	0.000547	CcSEcCtD
Norethindrone—Vomiting—Losartan—type 2 diabetes mellitus	6.52e-05	0.000526	CcSEcCtD
Norethindrone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000523	CcSEcCtD
Norethindrone—Nausea—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000522	CcSEcCtD
Norethindrone—Rash—Losartan—type 2 diabetes mellitus	6.47e-05	0.000522	CcSEcCtD
Norethindrone—Dermatitis—Losartan—type 2 diabetes mellitus	6.46e-05	0.000521	CcSEcCtD
Norethindrone—Headache—Losartan—type 2 diabetes mellitus	6.42e-05	0.000518	CcSEcCtD
Norethindrone—Asthenia—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000509	CcSEcCtD
Norethindrone—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	6.28e-05	0.0138	CrCbGaD
Norethindrone—Pruritus—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000502	CcSEcCtD
Norethindrone—Etonogestrel—CYP3A4—type 2 diabetes mellitus	6.1e-05	0.0134	CrCbGaD
Norethindrone—Nausea—Losartan—type 2 diabetes mellitus	6.09e-05	0.000491	CcSEcCtD
Norethindrone—Progesterone—SHBG—type 2 diabetes mellitus	5.91e-05	0.013	CrCbGaD
Norethindrone—Dizziness—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000469	CcSEcCtD
Norethindrone—ABCB1—liver—type 2 diabetes mellitus	5.67e-05	0.00733	CbGeAlD
Norethindrone—Vomiting—Ramipril—type 2 diabetes mellitus	5.59e-05	0.000451	CcSEcCtD
Norethindrone—Testosterone—SHBG—type 2 diabetes mellitus	5.59e-05	0.0123	CrCbGaD
Norethindrone—Rash—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000447	CcSEcCtD
Norethindrone—Dermatitis—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000447	CcSEcCtD
Norethindrone—Headache—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000444	CcSEcCtD
Norethindrone—Nausea—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000421	CcSEcCtD
Norethindrone—Progesterone—AR—type 2 diabetes mellitus	5.18e-05	0.0114	CrCbGaD
Norethindrone—Drospirenone—PTGS2—type 2 diabetes mellitus	5.18e-05	0.0114	CrCbGaD
Norethindrone—Testosterone—AR—type 2 diabetes mellitus	4.9e-05	0.0108	CrCbGaD
Norethindrone—Levonorgestrel—CYP3A4—type 2 diabetes mellitus	4.32e-05	0.00947	CrCbGaD
Norethindrone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	4.32e-05	0.00947	CrCbGaD
Norethindrone—Danazol—CYP3A4—type 2 diabetes mellitus	3.93e-05	0.00862	CrCbGaD
Norethindrone—Ethinyl Estradiol—CYP3A4—type 2 diabetes mellitus	3.64e-05	0.00798	CrCbGaD
Norethindrone—Progesterone—NR3C1—type 2 diabetes mellitus	3.52e-05	0.00771	CrCbGaD
Norethindrone—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	3.32e-05	0.00729	CrCbGaD
Norethindrone—Progesterone—CYP1A2—type 2 diabetes mellitus	3.08e-05	0.00675	CrCbGaD
Norethindrone—Methyltestosterone—ALB—type 2 diabetes mellitus	2.9e-05	0.00636	CrCbGaD
Norethindrone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	2.5e-05	0.00549	CrCbGaD
Norethindrone—Progesterone—CYP3A4—type 2 diabetes mellitus	2.04e-05	0.00447	CrCbGaD
Norethindrone—Testosterone—CYP3A4—type 2 diabetes mellitus	1.93e-05	0.00423	CrCbGaD
Norethindrone—Testosterone—ALB—type 2 diabetes mellitus	1.68e-05	0.00369	CrCbGaD
Norethindrone—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	5.85e-06	0.000121	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	5.85e-06	0.000121	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	5.85e-06	0.000121	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	5.83e-06	0.00012	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	5.83e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.82e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	5.82e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	5.82e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	5.82e-06	0.00012	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	5.81e-06	0.00012	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	5.81e-06	0.00012	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	5.81e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.81e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.81e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.81e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	5.78e-06	0.000119	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	5.72e-06	0.000118	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	5.71e-06	0.000118	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CTGF—type 2 diabetes mellitus	5.71e-06	0.000118	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	5.68e-06	0.000117	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	5.68e-06	0.000117	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	5.68e-06	0.000117	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	5.68e-06	0.000117	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	5.65e-06	0.000117	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.64e-06	0.000116	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	5.61e-06	0.000116	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	5.61e-06	0.000116	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.58e-06	0.000115	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.57e-06	0.000115	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.57e-06	0.000115	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.54e-06	0.000114	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.53e-06	0.000114	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	5.52e-06	0.000114	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.48e-06	0.000113	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.46e-06	0.000113	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	5.44e-06	0.000112	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.38e-06	0.000111	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.36e-06	0.000111	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.36e-06	0.000111	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	5.34e-06	0.00011	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	5.33e-06	0.00011	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.32e-06	0.00011	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.27e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	5.26e-06	0.000109	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.26e-06	0.000108	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.26e-06	0.000108	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.23e-06	0.000108	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	5.22e-06	0.000108	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	5.22e-06	0.000108	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	5.22e-06	0.000108	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.18e-06	0.000107	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.18e-06	0.000107	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.18e-06	0.000107	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	5.13e-06	0.000106	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	5.12e-06	0.000106	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.1e-06	0.000105	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.09e-06	0.000105	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.09e-06	0.000105	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.09e-06	0.000105	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	5.08e-06	0.000105	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.04e-06	0.000104	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.04e-06	0.000104	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GCG—type 2 diabetes mellitus	5.04e-06	0.000104	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	5.04e-06	0.000104	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.02e-06	0.000104	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.01e-06	0.000103	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5e-06	0.000103	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.98e-06	0.000103	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.97e-06	0.000103	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.95e-06	0.000102	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	4.95e-06	0.000102	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.87e-06	0.000101	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.86e-06	0.0001	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.85e-06	0.0001	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	4.81e-06	9.93e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.77e-06	9.85e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.72e-06	9.74e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.72e-06	9.74e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.7e-06	9.7e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	4.68e-06	9.66e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.66e-06	9.61e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.65e-06	9.6e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	4.64e-06	9.57e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.61e-06	9.51e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.61e-06	9.51e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.6e-06	9.5e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.59e-06	9.48e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.58e-06	9.45e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.56e-06	9.41e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	4.55e-06	9.39e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.53e-06	9.35e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.52e-06	9.34e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.52e-06	9.34e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.5e-06	9.28e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.49e-06	9.27e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.48e-06	9.25e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.42e-06	9.11e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.42e-06	9.11e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.41e-06	9.11e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.4e-06	9.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.4e-06	9.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.4e-06	9.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.4e-06	9.09e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.36e-06	9.01e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.34e-06	8.97e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.34e-06	8.97e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	4.33e-06	8.95e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.32e-06	8.92e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.31e-06	8.89e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.27e-06	8.81e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.22e-06	8.71e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.22e-06	8.71e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.17e-06	8.61e-05	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	4.14e-06	8.55e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.14e-06	8.55e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.13e-06	8.53e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.06e-06	8.37e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	4.05e-06	8.36e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	4.03e-06	8.32e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	3.99e-06	8.23e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	3.99e-06	8.23e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.96e-06	8.16e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.93e-06	8.11e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.93e-06	8.1e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.9e-06	8.05e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.9e-06	8.05e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.88e-06	8.01e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.87e-06	8e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.87e-06	7.99e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.86e-06	7.97e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.86e-06	7.96e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.85e-06	7.94e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.83e-06	7.9e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.81e-06	7.86e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.81e-06	7.86e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.81e-06	7.85e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.8e-06	7.84e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.79e-06	7.82e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.76e-06	7.76e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.74e-06	7.72e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.72e-06	7.67e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.71e-06	7.66e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.66e-06	7.56e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.65e-06	7.53e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.63e-06	7.49e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.62e-06	7.46e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.59e-06	7.41e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.59e-06	7.41e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.56e-06	7.35e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.55e-06	7.33e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.53e-06	7.29e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.52e-06	7.27e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.5e-06	7.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.5e-06	7.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.5e-06	7.22e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.49e-06	7.21e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.48e-06	7.18e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.48e-06	7.17e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.47e-06	7.15e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.46e-06	7.15e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.41e-06	7.05e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.39e-06	7e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.38e-06	6.98e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.38e-06	6.98e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.38e-06	6.97e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.37e-06	6.96e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.35e-06	6.92e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.33e-06	6.87e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.33e-06	6.87e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.32e-06	6.84e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.29e-06	6.8e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.29e-06	6.79e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.28e-06	6.76e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.25e-06	6.71e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.2e-06	6.6e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.14e-06	6.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.14e-06	6.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.14e-06	6.48e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.14e-06	6.47e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.12e-06	6.44e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.08e-06	6.36e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.06e-06	6.32e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.05e-06	6.3e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.04e-06	6.27e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.01e-06	6.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.99e-06	6.17e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.99e-06	6.16e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.98e-06	6.14e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.96e-06	6.12e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.94e-06	6.07e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	2.92e-06	6.03e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.92e-06	6.02e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.9e-06	5.99e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.89e-06	5.96e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.88e-06	5.95e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.88e-06	5.95e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-06	5.93e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.87e-06	5.92e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.84e-06	5.86e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.84e-06	5.86e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—INS—type 2 diabetes mellitus	2.83e-06	5.84e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.82e-06	5.81e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.72e-06	5.62e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.72e-06	5.62e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.69e-06	5.56e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.64e-06	5.44e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.59e-06	5.35e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.54e-06	5.25e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	5.22e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.48e-06	5.13e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.48e-06	5.13e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	5.12e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.35e-06	4.84e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.35e-06	4.84e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.33e-06	4.82e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.33e-06	4.81e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.3e-06	4.75e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.28e-06	4.7e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.27e-06	4.69e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.24e-06	4.61e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.23e-06	4.6e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.23e-06	4.6e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	4.49e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	4.49e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.18e-06	4.49e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.14e-06	4.41e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.09e-06	4.31e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.08e-06	4.3e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.04e-06	4.21e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.03e-06	4.19e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2e-06	4.13e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	4.11e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.92e-06	3.97e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.89e-06	3.89e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.83e-06	3.78e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.83e-06	3.77e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.8e-06	3.71e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.79e-06	3.69e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.77e-06	3.65e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.56e-06	3.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.53e-06	3.16e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.4e-06	2.89e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.34e-06	2.77e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.34e-06	2.77e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.33e-06	2.74e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.23e-06	2.53e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-06	2.36e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	2.12e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	2.06e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.16e-07	1.27e-05	CbGpPWpGaD
